Home > Healthcare > Medical Devices > Therapeutic Devices > Defibrillators Market

Defibrillators Market Share

Report ID: GMI5495
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Defibrillators Market Share

Abbott Laboratories, Inc.
BIOTRONIK SE & Co. KG
AMI Italia
Boston Scientific Corporation
Koninklijke Philips N.V.
CU Medical Systems Co. Ltd
Stryker Corporation
Medtronic plc
MicroPort Scientific Corporation
Meditech Equipment Co., Ltd (Meditech Group)
Mindray Medical International Limited
BPL Medical Technologies Pvt Ltd
Nihon Kohden Corporation
Schiller AG
and ZOLL Medical Corporation (Asahi Kasei Group)

are some of the key participants involved in the defibrillators market.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global Market size for defibrillators was valued at more than USD 11 billion in 2022 and is primed to progress at over 6.5% CAGR between 2023 and 2032 propelled by surging incidences of sudden cardiac arrests and heart failures.

The implantable cardioverter defibrillator (ICD) segment held over 71% revenue share in 2022 as a result of the broad variety of product diversity, expanded application possibilities, and technical breakthroughs.

The hospitals end-use segment is anticipated to witness growth at more than 7% CAGR over 2023-2032 owing to increasing cases of cardiac arrest, the surge in need for ICD implantation procedures, and the accessibility of highly skilled healthcare personnel.

Europe market for defibrillators is slated to reach a value of over USD 6 billion by the end of 2032 accredited to rising occurrences of tachycardia due to hypertension, obesity, and dyslipidemia, among the elderly population in the region.